Correlation Between KABE Group and Zenicor Medical

Can any of the company-specific risk be diversified away by investing in both KABE Group and Zenicor Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining KABE Group and Zenicor Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between KABE Group AB and Zenicor Medical Systems, you can compare the effects of market volatilities on KABE Group and Zenicor Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in KABE Group with a short position of Zenicor Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of KABE Group and Zenicor Medical.

Diversification Opportunities for KABE Group and Zenicor Medical

0.11

Correlation Coefficient

KABE Group  Zenicor Medical

Average diversification

The 3 months correlation between KABE and Zenicor is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding KABE Group AB and Zenicor Medical Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zenicor Medical Systems and KABE Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on KABE Group AB are associated (or correlated) with Zenicor Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zenicor Medical Systems has no effect on the direction of KABE Group i.e., KABE Group and Zenicor Medical go up and down completely randomly.

Pair Corralation between KABE Group and Zenicor Medical

Assuming the 90 days trading horizon KABE Group AB is expected to generate 0.35 times more return on investment than Zenicor Medical. However, KABE Group AB is 2.83 times less risky than Zenicor Medical. It trades about -0.14 of its potential returns per unit of risk. Zenicor Medical Systems is currently generating about -0.08 per unit of risk. If you would invest  31,500  in KABE Group AB on September 12, 2024 and sell it today you would lose (1,600) from holding KABE Group AB or give up 5.08% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

KABE Group AB  vs.  Zenicor Medical Systems

KABE Group AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days KABE Group AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental drivers, KABE Group is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Zenicor Medical Systems

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Zenicor Medical Systems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Zenicor Medical is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with KABE Group and Zenicor Medical

The main advantage of trading using opposite KABE Group and Zenicor Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if KABE Group position performs unexpectedly, Zenicor Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zenicor Medical will offset losses from the drop in Zenicor Medical's long position.

The idea behind KABE Group AB and Zenicor Medical Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.